🟢 MKKGY is trading 5.3% up today after announcing an $11.3 billion deal to acquire Bio-Techne

MKKGY is trading +5.34% higher at $33.55 after Merck KGaA announced an $11.3 billion all-cash deal to acquire Bio-Techne.

• The transaction is priced at $73 per share, representing a 36% premium over previous trading levels.
• The acquisition serves as a strong company-specific catalyst, with the stock significantly outperforming a weaker broader market.